APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mumps Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mumps Drug Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchMumps Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Mumps Drug Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Mumps Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mumps Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mumps Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mumps Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mumps Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mumps Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mumps Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mumps Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mumps Drug market include GlaxoSmithKline Plc, Beijing Tiantan Biological Products Co., Ltd., Beijing Minhai Biotechnology Co., Ltd, Zydus Cadila Healthcare Limited, Sinovac Biotech Ltd., Prometheon Pharma, LLC, Organic Vaccines and China National Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mumps Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mumps Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mumps Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mumps Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Mumps Drug Segment by Company

GlaxoSmithKline Plc

Beijing Tiantan Biological Products Co., Ltd.

Beijing Minhai Biotechnology Co., Ltd

Zydus Cadila Healthcare Limited

Sinovac Biotech Ltd.

Prometheon Pharma, LLC

Organic Vaccines

China National Pharmaceutical Group Corporation

Mumps Drug Segment by Type

RIT 4385

Wistar RA 27/3

Schwarz

Others

Mumps Drug Segment by Application

Hospital

Clinic

Others

Mumps Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mumps Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mumps Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mumps Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Mumps Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mumps Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mumps Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mumps Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mumps Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mumps Drug industry.

Chapter 3: Detailed analysis of Mumps Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mumps Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mumps Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mumps Drug Industry Trends Table 2. Mumps Drug Industry Drivers Table 3. Mumps Drug Industry Opportunities and Challenges Table 4. Mumps Drug Industry Restraints Table 5. Global Mumps Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mumps Drug Revenue Share by Company (2021-2026) Table 7. Global Mumps Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Mumps Drug Sales Volume Share by Company (2021-2026) Table 9. Global Mumps Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Mumps Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mumps Drug Key Company Manufacturing Base & Headquarters Table 12. Global Mumps Drug Company, Product Type & Application Table 13. Global Mumps Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mumps Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of RIT 4385 Table 18. Significant Companies of Wistar RA 27/3 Table 19. Significant Companies of Schwarz Table 20. Significant Companies of Others Table 21. Global Mumps Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Mumps Drug Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Mumps Drug Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Mumps Drug Sales Volume Share by Type (2021-2026) Table 25. Global Mumps Drug Sales Volume Share by Type (2027-2032) Table 26. Global Mumps Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mumps Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Mumps Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Mumps Drug Sales Value Share by Type (2021-2026) Table 30. Global Mumps Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Significant Companies of Others Table 34. Global Mumps Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Mumps Drug Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Mumps Drug Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Mumps Drug Sales Volume Share by Application (2021-2026) Table 38. Global Mumps Drug Sales Volume Share by Application (2027-2032) Table 39. Global Mumps Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Mumps Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Mumps Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Mumps Drug Sales Value Share by Application (2021-2026) Table 43. Global Mumps Drug Sales Value Share by Application (2027-2032) Table 44. Global Mumps Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Mumps Drug Sales by Region (2021-2026) & (W Units) Table 46. Global Mumps Drug Sales Market Share by Region (2021-2026) Table 47. Global Mumps Drug Sales by Region (2027-2032) & (W Units) Table 48. Global Mumps Drug Sales Market Share by Region (2027-2032) Table 49. Global Mumps Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Mumps Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Mumps Drug Sales Value Share by Region (2021-2026) Table 52. Global Mumps Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Mumps Drug Sales Value Share by Region (2027-2032) Table 54. Global Mumps Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Mumps Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Mumps Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Mumps Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Mumps Drug Sales by Country (2021-2026) & (W Units) Table 59. Global Mumps Drug Sales Market Share by Country (2021-2026) Table 60. Global Mumps Drug Sales by Country (2027-2032) & (W Units) Table 61. Global Mumps Drug Sales Market Share by Country (2027-2032) Table 62. Global Mumps Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Mumps Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Mumps Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Mumps Drug Sales Value Market Share by Country (2027-2032) Table 66. GlaxoSmithKline Plc Company Information Table 67. GlaxoSmithKline Plc Business Overview Table 68. GlaxoSmithKline Plc Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. GlaxoSmithKline Plc Mumps Drug Product Portfolio Table 70. GlaxoSmithKline Plc Recent Development Table 71. Beijing Tiantan Biological Products Co., Ltd. Company Information Table 72. Beijing Tiantan Biological Products Co., Ltd. Business Overview Table 73. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolio Table 75. Beijing Tiantan Biological Products Co., Ltd. Recent Development Table 76. Beijing Minhai Biotechnology Co., Ltd Company Information Table 77. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 78. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolio Table 80. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 81. Zydus Cadila Healthcare Limited Company Information Table 82. Zydus Cadila Healthcare Limited Business Overview Table 83. Zydus Cadila Healthcare Limited Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zydus Cadila Healthcare Limited Mumps Drug Product Portfolio Table 85. Zydus Cadila Healthcare Limited Recent Development Table 86. Sinovac Biotech Ltd. Company Information Table 87. Sinovac Biotech Ltd. Business Overview Table 88. Sinovac Biotech Ltd. Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sinovac Biotech Ltd. Mumps Drug Product Portfolio Table 90. Sinovac Biotech Ltd. Recent Development Table 91. Prometheon Pharma, LLC Company Information Table 92. Prometheon Pharma, LLC Business Overview Table 93. Prometheon Pharma, LLC Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Prometheon Pharma, LLC Mumps Drug Product Portfolio Table 95. Prometheon Pharma, LLC Recent Development Table 96. Organic Vaccines Company Information Table 97. Organic Vaccines Business Overview Table 98. Organic Vaccines Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Organic Vaccines Mumps Drug Product Portfolio Table 100. Organic Vaccines Recent Development Table 101. China National Pharmaceutical Group Corporation Company Information Table 102. China National Pharmaceutical Group Corporation Business Overview Table 103. China National Pharmaceutical Group Corporation Mumps Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. China National Pharmaceutical Group Corporation Mumps Drug Product Portfolio Table 105. China National Pharmaceutical Group Corporation Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Mumps Drug Distributors List Table 109. Mumps Drug Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Mumps Drug Product Image Figure 2. Global Mumps Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mumps Drug Sales (2021-2032) & (W Units) Figure 5. Global Mumps Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Mumps Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. RIT 4385 Image Figure 10. Wistar RA 27/3 Image Figure 11. Schwarz Image Figure 12. Others Image Figure 13. Global Mumps Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Mumps Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Mumps Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Mumps Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Mumps Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Mumps Drug Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Others Image Figure 22. Global Mumps Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Mumps Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Mumps Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Mumps Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Mumps Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Mumps Drug Sales Value Share by Application (2021-2032) Figure 28. Global Mumps Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Mumps Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Mumps Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Mumps Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Mumps Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Mumps Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Mumps Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Mumps Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Mumps Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Mumps Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Mumps Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Mumps Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Mumps Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Mumps Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Mumps Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • RIT 4385
  • Wistar RA 27/3
  • Schwarz
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • GlaxoSmithKline Plc
  • Beijing Tiantan Biological Products Co., Ltd.
  • Beijing Minhai Biotechnology Co., Ltd
  • Zydus Cadila Healthcare Limited
  • Sinovac Biotech Ltd.
  • Prometheon Pharma, LLC
  • Organic Vaccines
  • China National Pharmaceutical Group Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mumps Drug Sales Value (2021-2032)
  4. 1.2.2 Global Mumps Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Mumps Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mumps Drug Market Dynamics
  1. 2.1 Mumps Drug Industry Trends
  2. 2.2 Mumps Drug Industry Drivers
  3. 2.3 Mumps Drug Industry Opportunities and Challenges
  4. 2.4 Mumps Drug Industry Restraints
3 Mumps Drug Market by Company
  1. 3.1 Global Mumps Drug Company Revenue Ranking in 2025
  2. 3.2 Global Mumps Drug Revenue by Company (2021-2026)
  3. 3.3 Global Mumps Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Mumps Drug Average Price by Company (2021-2026)
  5. 3.5 Global Mumps Drug Company Ranking (2024-2026)
  6. 3.6 Global Mumps Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Mumps Drug Company Product Type and Application
  8. 3.8 Global Mumps Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mumps Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mumps Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mumps Drug Market by Type
  1. 4.1 Mumps Drug Type Introduction
  2. 4.1.1 RIT 4385
  3. 4.1.2 Wistar RA 27/3
  4. 4.1.3 Schwarz
  5. 4.1.4 Others
  6. 4.2 Global Mumps Drug Sales Volume by Type
  7. 4.2.1 Global Mumps Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Mumps Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Mumps Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Mumps Drug Sales Value by Type
  11. 4.3.1 Global Mumps Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Mumps Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Mumps Drug Sales Value Share by Type (2021-2032)
5 Mumps Drug Market by Application
  1. 5.1 Mumps Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Mumps Drug Sales Volume by Application
  6. 5.2.1 Global Mumps Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mumps Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mumps Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mumps Drug Sales Value by Application
  10. 5.3.1 Global Mumps Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mumps Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mumps Drug Sales Value Share by Application (2021-2032)
6 Mumps Drug Regional Sales and Value Analysis
  1. 6.1 Global Mumps Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mumps Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Mumps Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Mumps Drug Sales by Region (2027-2032)
  5. 6.3 Global Mumps Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mumps Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mumps Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mumps Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Mumps Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mumps Drug Sales Value (2021-2032)
  12. 6.6.2 North America Mumps Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mumps Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Mumps Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mumps Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mumps Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mumps Drug Sales Value (2021-2032)
  21. 6.9.2 South America Mumps Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mumps Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mumps Drug Sales Value Share by Country, 2025 VS 2032
7 Mumps Drug Country-level Sales and Value Analysis
  1. 7.1 Global Mumps Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mumps Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mumps Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Mumps Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Mumps Drug Sales by Country (2027-2032)
  6. 7.4 Global Mumps Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mumps Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mumps Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mumps Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mumps Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mumps Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mumps Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mumps Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mumps Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mumps Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mumps Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mumps Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mumps Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mumps Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mumps Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mumps Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mumps Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mumps Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mumps Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mumps Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mumps Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mumps Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mumps Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mumps Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mumps Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mumps Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mumps Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mumps Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mumps Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mumps Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mumps Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mumps Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mumps Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mumps Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mumps Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mumps Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mumps Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mumps Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mumps Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mumps Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mumps Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mumps Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mumps Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mumps Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mumps Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mumps Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mumps Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mumps Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mumps Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mumps Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mumps Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mumps Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mumps Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mumps Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mumps Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mumps Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mumps Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mumps Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mumps Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mumps Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mumps Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mumps Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mumps Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mumps Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mumps Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mumps Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mumps Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mumps Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mumps Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mumps Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mumps Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mumps Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mumps Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mumps Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mumps Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mumps Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mumps Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mumps Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mumps Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mumps Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mumps Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mumps Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mumps Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mumps Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mumps Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mumps Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mumps Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline Plc
  2. 8.1.1 GlaxoSmithKline Plc Company Information
  3. 8.1.2 GlaxoSmithKline Plc Business Overview
  4. 8.1.3 GlaxoSmithKline Plc Mumps Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Plc Mumps Drug Product Portfolio
  6. 8.1.5 GlaxoSmithKline Plc Recent Developments
  7. 8.2 Beijing Tiantan Biological Products Co., Ltd.
  8. 8.2.1 Beijing Tiantan Biological Products Co., Ltd. Company Information
  9. 8.2.2 Beijing Tiantan Biological Products Co., Ltd. Business Overview
  10. 8.2.3 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Tiantan Biological Products Co., Ltd. Mumps Drug Product Portfolio
  12. 8.2.5 Beijing Tiantan Biological Products Co., Ltd. Recent Developments
  13. 8.3 Beijing Minhai Biotechnology Co., Ltd
  14. 8.3.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  15. 8.3.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  16. 8.3.3 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Minhai Biotechnology Co., Ltd Mumps Drug Product Portfolio
  18. 8.3.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  19. 8.4 Zydus Cadila Healthcare Limited
  20. 8.4.1 Zydus Cadila Healthcare Limited Company Information
  21. 8.4.2 Zydus Cadila Healthcare Limited Business Overview
  22. 8.4.3 Zydus Cadila Healthcare Limited Mumps Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Cadila Healthcare Limited Mumps Drug Product Portfolio
  24. 8.4.5 Zydus Cadila Healthcare Limited Recent Developments
  25. 8.5 Sinovac Biotech Ltd.
  26. 8.5.1 Sinovac Biotech Ltd. Company Information
  27. 8.5.2 Sinovac Biotech Ltd. Business Overview
  28. 8.5.3 Sinovac Biotech Ltd. Mumps Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sinovac Biotech Ltd. Mumps Drug Product Portfolio
  30. 8.5.5 Sinovac Biotech Ltd. Recent Developments
  31. 8.6 Prometheon Pharma, LLC
  32. 8.6.1 Prometheon Pharma, LLC Company Information
  33. 8.6.2 Prometheon Pharma, LLC Business Overview
  34. 8.6.3 Prometheon Pharma, LLC Mumps Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Prometheon Pharma, LLC Mumps Drug Product Portfolio
  36. 8.6.5 Prometheon Pharma, LLC Recent Developments
  37. 8.7 Organic Vaccines
  38. 8.7.1 Organic Vaccines Company Information
  39. 8.7.2 Organic Vaccines Business Overview
  40. 8.7.3 Organic Vaccines Mumps Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Organic Vaccines Mumps Drug Product Portfolio
  42. 8.7.5 Organic Vaccines Recent Developments
  43. 8.8 China National Pharmaceutical Group Corporation
  44. 8.8.1 China National Pharmaceutical Group Corporation Company Information
  45. 8.8.2 China National Pharmaceutical Group Corporation Business Overview
  46. 8.8.3 China National Pharmaceutical Group Corporation Mumps Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 China National Pharmaceutical Group Corporation Mumps Drug Product Portfolio
  48. 8.8.5 China National Pharmaceutical Group Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mumps Drug Value Chain Analysis
  2. 9.1.1 Mumps Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mumps Drug Sales Mode & Process
  6. 9.2 Mumps Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mumps Drug Distributors
  9. 9.2.3 Mumps Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst